Delivery Order SPE2DB20D1100-SPE2DB25FE1D5
Award Date 8/15/25
Potential Completion Date 8/18/25
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Visipaque 320 mg/ml infusion bottles (150 ml units) with a ceiling value of $4,126.40. This firm fixed-price delivery order, which is expected to be completed by August 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion through December 2026. The award was...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,296.38 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml in 100ml bottles. This competitively awarded, firm fixed price contract was executed on July 24, 2025, with an ultimate completion date of July 25, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,650.56 to AmerisourceBergen Drug Corp for Visipaque 320 mg/mL intravenous solution in 150 mL bottles. This competitive award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, reflects a firm fixed-price contract type with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Visipaque 270 mg/ml in 150 ml bottles, valued at $1,599.09 with a firm fixed price arrangement. The contract requires completion by September 8, 2025, and represents a non-set-aside award issued through open competition. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $32,271.62 by the Medical Supply Chain, a component of the Department of Defense, for the supply of Visipaque 320 mg/ml in 100 ml bottles. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 14, 2025, and represents a non-set-aside procurement. The contract was executed on August 13, 2025, with performance to take place at AmerisourceBergen's corporate office location in...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Visipaque 320 mg/mL in 100 mL bottles with a ceiling value of $4,216.05 on August 29, 2025. This is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and carries no set-aside designation. The order was competitively awarded and represents a child contract under AmerisourceBergen's larger contract vehicle with the Defense Logistics Agency. AmerisourceBergen,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,687.64 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VISIPAQUE 320 MG/ML INFUS BTL 150ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical...
- This federal contract award, valued at $4,169.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Visipaque 320 mg/ml infusion bottles, a specialty pharmaceutical product. The contract is a delivery order with a firm fixed price and has an ultimate completion date of November 17, 2023. The award was made on November 16, 2023. There is no set-aside designation...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML. The $1,687.64 order has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is a prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Visipaque 320 mg/ml, a pharmaceutical product, with a ceiling value of $26,715.17 and a period of performance through July 3, 2025. The contract is a firm-fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen holds a...